<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<ArticleSet>
<Article>
<Journal>
<PublisherName>journal-jmsr</PublisherName>
<JournalTitle>Journal of Medical and Surgical Research</JournalTitle>
<PISSN>I</PISSN>
<EISSN>S</EISSN>
<Volume-Issue>Vol. VI, n 2</Volume-Issue>
<PartNumber/>
<IssueTopic>Multidisciplinary</IssueTopic>
<IssueLanguage>English</IssueLanguage>
<Season>December 2019</Season>
<SpecialIssue>N</SpecialIssue>
<SupplementaryIssue>N</SupplementaryIssue>
<IssueOA>Y</IssueOA>
<PubDate>
<Year>-0001</Year>
<Month>11</Month>
<Day>30</Day>
</PubDate>
<ArticleType>JMSR Diabetes & Endocriniology</ArticleType>
<ArticleTitle>Latest News on Autoantibodies Associated with type 1 Diabetes in Children: -Systematic Review-</ArticleTitle>
<SubTitle/>
<ArticleLanguage>English</ArticleLanguage>
<ArticleOA>Y</ArticleOA>
<FirstPage>645</FirstPage>
<LastPage>651</LastPage>
<AuthorList>
<Author>
<FirstName>Belhiba</FirstName>
<LastName>Ouijdane</LastName>
<AuthorLanguage>English</AuthorLanguage>
<Affiliation/>
<CorrespondingAuthor>N</CorrespondingAuthor>
<ORCID/>
<FirstName>Ahmed Aziz</FirstName>
<LastName>Bousfiha</LastName>
<AuthorLanguage>English</AuthorLanguage>
<Affiliation/>
<CorrespondingAuthor>Y</CorrespondingAuthor>
<ORCID/>
<FirstName>Farida</FirstName>
<LastName>Jennane</LastName>
<AuthorLanguage>English</AuthorLanguage>
<Affiliation/>
<CorrespondingAuthor>Y</CorrespondingAuthor>
<ORCID/>
</Author>
</AuthorList>
<DOI/>
<Abstract>Type 1 diabetes in children is a chronic autoimmune disease related to the destruction of islet cells __ampersandsignbeta; by an autoimmune process. The clinical symptoms are preceded by a prediabetic phase during which many autoantibodies can be detected in patients, such as anti-glutamic acid decarboxylase (GADA), anti-insulin (IAA), anti-tyrosine phosphatase (IA2-AAb), Langerhans anti-islet (ICA) and zinc transporter 8 (ZnT8-AAb). Recently, they have reported tree new autoantibodies: elongation factor of eukaryotic translation 1 alpha 1 autoantibody (EEF1A1-AAb), autoantibodies 2L3 (UBE2L3-AAb), the enzyme involved in protein degradation, for ubiquitin conjugation, and autoantibodies GLIMA 38. Our objective is to develop the latest news on autoantibodies specific for autoantigens expressed in pancreatic __ampersandsignbeta; cells, their targets, as also their prevalence and predictive values.</Abstract>
<AbstractLanguage>English</AbstractLanguage>
<Keywords>Autoimmunity, Autoantibodies, Children, Diabetes type 1</Keywords>
<URLs>
<Abstract>https://journal-jmsr.net/ubijournal-v1copy/journals/abstract.php?article_id=6699&title=Latest News on Autoantibodies Associated with type 1 Diabetes in Children: -Systematic Review-</Abstract>
</URLs>
<References>
<ReferencesarticleTitle>References</ReferencesarticleTitle>
<ReferencesfirstPage>16</ReferencesfirstPage>
<ReferenceslastPage>19</ReferenceslastPage>
<References>1. OMS | Faits et chiffres sur le diaband;egrave;te - infographies. WHO. http://www.who.int/diabetes/infographic/fr/. Accessed October 3, 2018.
2. IDF_Diabetes_Atlas_8e_FR_final.pdf.
3. Monnier L, Colette Cl. Chapitre 4 - Dand;eacute;couverte d’un diaband;egrave;te detype1. In: Monnier L, Colette C, eds. Diaband;eacute;tologie?: 55 Dand;eacute;marches Cliniques En Pratique Mand;eacute;dicale ; 2017:45-61.
4. Craig ME, Jefferies C, Dabelea D, Balde N, Seth A, Donaghue KC. Definition, epidemiology, and classification of diabetes in children and adolescents: Definition, epidemiology, and classification of diabetes. Pediatric Diabetes. 2014;15(S20):4-17. doi:10.1111/pedi.12186
5. Wand;eacute;meau J-L. Chapitre 15 - Le diaband;egrave;te de type 1. In: Wand;eacute;meau J-L, ed. Endocrinologie, Diaband;egrave;te, Mand;eacute;tabolisme et Nutrition Pour Le Praticien. 2014:215-225.
6. Durand G, Beaudeux J-L. Biochimie mand;eacute;dicale: Marqueurs actuels et perspectives. Lavoisier; 2011.
7. Kikkas I, Mallone R, Larger E, Volland H, Morel N. A Rapid Lateral Flow Immunoassay for the Detection of Tyrosine Phosphatase-Like Protein IA-2 Autoantibodies in Human Serum. Sechi LA, ed. PLoS ONE. 2014;9(7):e103088.
8. Mayer-Davis EJ, Kahkoska AR, Jefferies C, et al. ISPAD Clinical Practice Consensus Guidelines 2018: Definition, epidemiology, and classification of diabetes in children and adolescents. Pediatric Diabetes. 2018;19:7-19.
9. Belkhadir J.Diabetes and prospect of national and global disaster. Journal of Medical and Surgical Research -JMSR-; 2015, I (3): 77-78.
10. Ugwu ET. Incorporating results into diabetes self-care plan rather than frequency of glycemic monitoring improves glycemic control in insulin treated subjects with type 2 diabetes mellitus. Journal of Medical and Surgical Research -JMSR-; 2017, IV (1): 397- 402.
11. Diane W., Cand;eacute;line H., Beth M., Daniand;egrave;le P., Le diaband;egrave;te de type 1 chez les enfants et les adolescents, Candien Journal of Diabetes, 2013, 37, s531-s541
12. Chandalia HB, Research Society for the Study of Diabetes in India. RSSDI Textbook of Diabetes Mellitus.; 2014.
13. Watkins RA, Evans-Molina C, Blum JS, DiMeglio LA. Established and emerging biomarkers for the prediction of type 1 diabetes: a systematic review. Translational Research. 2014;164(2):110-121.
14. Oikawa Y, Tanaka H, Uchida J, et al. Slowly progressive insulin-dependent (type 1) diabetes positive for anti-GAD antibody ELISA test may be strongly associated with a future insulin-dependent state. Endocrine Journal. 2017;64(2):163-170.
15. Knip M, Korhonen S, Kulmala P, et al. Prediction of Type 1 Diabetes in the General Population. Diabetes Care. 2010;33(6):1206-1212.
16. Howson JMM, Stevens H, Smyth DJ, et al. Evidence That HLA Class I and II Associations With Type 1 Diabetes, Autoantibodies to GAD and Autoantibodies to IA-2, Are Distinct. Diabetes. 2011;60(10):2635-2644.
17. Lampasona V, Liberati D. Islet Autoantibodies. Current Diabetes Reports. 2016;16(6).
18. Monnier L, Fumat C. Diaband;eacute;tologie. Issy-les-Moulineaux: Elsevier Masson; 2010.
19. Soltani N, Qiu H, Aleksic M, et al. GABA exerts protective and regenerative effects on islet beta cells and reverses diabetes. Proceedings of the National Academy of Sciences. 2011;108(28):11692-11697.
20. Nonnenmacher L. Informations Rand;eacute;actifs?: Insuline, Peptide C, anticorps anti-ICA, anti-GAD65, anti-IA2 et anti-insuline. Immuno-analyse and; Biologie Spand;eacute;cialisand;eacute;e. 2002;17(3):185-198.
21. Jin T, Yu H, Huang X-F. Selective binding modes and allosteric inhibitory effects of lupane triterpenes on protein tyrosine phosphatase 1B. Scientific Reports. 2016;6(1).
22. Fabien N. Les anticorps anti-ZnT8. Revue Francophone des Laboratoires. 2014;2014(464):45-47.
23. Koo BK, Chae S, Kim KM, et al. Identification of Novel Autoantibodies in Type 1 Diabetic Patients Using a High-Density Protein Microarray. Diabetes. 2014;63(9):3022-3032.
24. Kim EG, Kwak SH, Hwang D, et al. The Level of Autoantibodies Targeting Eukaryote Translation Elongation Factor 1 and;alpha;1 and Ubiquitin-Conjugating Enzyme 2L3 in Nondiabetic Young Adults. Diabetes and; Metabolism Journal. 2016;40(2):154.
25. McLaughlin KA, Richardson CC, Ravishankar A, et al. Identification of Tetraspanin-7 as a Target of Autoantibodies in Type 1 Diabetes. Diabetes. 2016;65(6):1690-1698.
26. Bouhours-Nouet N, Coutant R. Clinique et diagnostic du diaband;egrave;te de l’enfant. EMC - Pand;eacute;diatrie. 2005;2(3):220-242.
27. OMS | Mieux connaand;icirc;tre le diaband;egrave;te. WHO. http://www.who.int/diabetes/action_online/basics/fr/. Accessed October 3, 2018.
28. American Diabetes Association. 2. Classification and Diagnosis of Diabetes. Diabetes Care. 2017;40 (Supplement 1):S11-S24.</References>
</References>
</Journal>
</Article>
</ArticleSet>